|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4381 USD | +21.69% |
|
+21.69% | +39.97% |
| 03-17 | LAMY Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2025 | CI |
| 11-17 | LAMY Announces Board Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 23M | - | - | - | - | - |
| 43.13B | |||||
| 34.65B | - | - | - | - | - |
| 30.03B | |||||
| 28B | |||||
| 24.45B |
- Stock Market
- Stocks
- LMMY Stock
- Charts LAMY
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
